Literature DB >> 6169277

Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.

F Mantero, D Armanini, G Opocher, F Fallo, L Sampieri, B Cuspidi, C Ambrosi, G Faglia.   

Abstract

The finding of hypokalemia and of low plasma renin activity (PRA) in a hypertensive patient suggests a diagnosis of primary hypermineralocorticoidism. Medications containing compounds with mineralocorticoid-like activity (licorice, carbenexolone) may also cause the same syndrome. Recently, we carried out detailed studies on 10 patients with severe hypertension and hypokalemic alkalosis, suppressed PRA and low aldosterone levels. Plasma levels of cortisol and ACTH were suppressed in most of the cases. Measurement of deoxycorticosterone and corticosterone (and in some patient of 18-hydroxydeoxycorticosterone and 18-hydroxycorticosterone) was not significantly higher than normal. Therapeutic trials of dexamethasone and aminoglutethimide were ineffective. In contrast, spironolactone and amiloride treatment resulted in substantial but incomplete amelioration of both hypertension and hypokalemia. All of the patients share a common history of chronic rhinitis and habitual use of large doses of nasal spray containing 9 alpha-fluoroprednisolone and vasoconstrictor agents. Withdrawal resulted in a complete remission of hypokalemia in one to two weeks in all patients. The hypertension and depressed levels of PRA, aldosterone and cortisol took longer to return to normal, varying from case to case; in all but one patient, the values returned to normal within two months. This report reveals another cause of factitious mineralocorticoid excess which may be considered in the differential diagnosis of hypokalemic hypertensive syndromes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169277     DOI: 10.1016/0002-9343(81)90150-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Factitious hypermineralcorticoidism by chronic use of 9-alpha-fluoroprednisolone containing collyrium.

Authors:  M Errico; M Freda; M Zingrillo; M Grilli
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

Review 2.  Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism.

Authors:  Peter J Fuller
Journal:  Clin Biochem Rev       Date:  2013-11

3.  Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment.

Authors:  R Pedrinelli; A Lucarini; L Graziadei; S Taddei; A Salvetti
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

Review 4.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Systemic Hypertension Induced by Harpagophytum procumbens (devil's claw): A Case Report.

Authors:  Cesare Cuspidi; Carla Sala; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-19       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.